US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

108.06

-0.0800-0.07%

Post-market: 108.060.00000.00%19:30 EDT

Volume:272.52K

Turnover:29.38M

Market Cap:1.01B

PE:87.56

High:108.33

Open:108.14

Low:107.29

Close:108.14

52wk High:118.00

52wk Low:90.60

Shares:9.39M

Float Shares:9.39M

Volume Ratio:0.61

T/O Rate:2.90%

Dividend:2.18

Dividend Rate:2.02%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):139.17

Loading ...

Overview Company News Filings

Merck says FDA approves update for U.S. product label for Winrevair

U.S. FDA Approves Update to the Label for Winrevair to Include Data from the Phase 3 Hyperion Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension

Merck Says Phase 3 Hyperion Trial Shows Winrevair Cuts PAH Clinical Worsening Risk 76%

Novo Nordisk Investor Day Disappointed

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

Market Chatter: Novo Nordisk CEO Eyes M&A to Fill Gaps in Drug Portfolio

MT Newswires Live

Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’

Novo Nordisk (0QIU) Receives a Hold from Berenberg Bank

Novo Nordisk Investors Remain Nervous, but Share Drop an Overreaction

Novo Nordisk's Underwhelming Investor Day Met with Punishing Response

AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)

Novo Nordisk's Share Fall After Investor Day Seems Harsh

AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis

Abbvie Announces European Commission Approval of Rinvoq® (Upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

THOMSON REUTERS

Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older

THOMSON REUTERS

Novo Nordisk Investor Day Offered Little to Excite

Novo Nordisk Highlights Building Blocks, but More Data Needed to Reassure Investors

Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site

MT Newswires Live

Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston

THOMSON REUTERS

Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/PPH/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":108.06,"timestamp":1790971200000,"preClose":108.14,"halted":0,"volume":272520,"hourTrading":{"tag":"盘后","latestPrice":108.06,"preClose":108.06,"latestTime":"19:30 EDT","volume":40,"amount":4324.26,"timestamp":1790983847593,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0007397817643794922,"floatShares":9388138,"shares":9388138,"eps":1.234146,"marketStatus":"Market Closed","change":-0.08,"latestTime":"10-02 16:00:00 EDT","open":108.14,"high":108.325,"low":107.29,"amount":29378216.0286,"amplitude":0.009571,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.14,"sharesOutstanding":11938138,"nav":108.04699,"aum":1014360012.4,"dividendRate":0.020154,"bidAskSpread":0.000353,"preHourTrading":{"tag":"盘前","latestPrice":108.61,"preClose":108.14,"latestTime":"08:05 EDT","volume":7,"amount":766.507798,"timestamp":1790942726383,"change":0.47,"changeRate":0.004346,"amplitude":0.021052},"postHourTrading":{"tag":"盘后","latestPrice":108.06,"preClose":108.06,"latestTime":"19:30 EDT","volume":40,"amount":4324.26,"timestamp":1790983847593,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6059622308904572,"impliedVol":0.2234,"impliedVolPercentile":0.8008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9388138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.6059622308904572,"shares":9388138,"dividePrice":2.1778,"high":108.325,"amplitude":0.009571,"preClose":108.14,"low":107.29,"week52Low":90.6,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":108.06,"eps":1.234146,"divideRate":0.020154,"volume":272520,"delay":0,"ttmEps":1.234146,"open":108.14,"prevYearClose":103.17,"prevWeekClose":111.35,"prevMonthClose":109.47,"prevQuarterClose":109.47,"fiveDayClose":111.35,"twentyDayClose":115.77,"sixtyDayClose":109.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-10-01","symbol":"PPH","amount":0.36,"announcedDate":"2026-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-01","defaultRemindTime":1790861400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-06","payableDate":"2026-10-01","currency":"USD","dateTimestamp":1790827200000,"payDate":"2026-10-06"},{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-03","recordDate":"2016-10-05","paymentDate":"2016-10-07","value":0.2148,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669146630","title":"Merck says FDA approves update for U.S. product label for Winrevair","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146630?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:50","pubTimestamp":1790074233,"startTime":"0","endTime":"0","summary":"Merck (MRK) announced the U.S. FDA has approved an update to the U.S. product label for Winrevair for injection, 45mg, 60mg, based on the Phase 3 H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-says-fda-approves-update-for-u-s-product-label-for-winrevair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-says-fda-approves-update-for-u-s-product-label-for-winrevair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU1023059063.AUD","LU2125154935.USD","LU2361044865.SGD","LU1116320737.USD","LU0320765646.SGD","LU2468319806.SGD","LU2089984988.USD","FHLC","IE00BJT1NW94.SGD","BK4516","IE00BN8TJ469.HKD","LU0106261372.USD","LU1983299246.USD","LU1162221912.USD","LU1699723380.USD","LU1066053197.SGD","BK4007","LU0289961442.SGD","LU2433249047.HKD","LU0965509101.SGD","LU2360032135.SGD","BK4559","IHE","IE00B4R5TH58.HKD","GDOC","LU1061106388.HKD","LU2125909247.SGD","IE00B2B36J28.USD","LU0985320562.USD","LU0122379950.USD","LU0859254822.USD","LU2112291526.USD","IXJ","LU0823416689.USD","LU1037948541.HKD","PPH","LU0472753341.HKD","SG9999015341.SGD","IYH","LU0130102774.USD","LU0070302665.USD","LU1923622614.USD","BK4588","SG9999001176.USD","LU0289739343.SGD","SG9999002224.SGD","LU1093756325.SGD","IE00BLSP4239.USD","BMED","LU1989772923.USD","LU2023250504.SGD","IE0009355771.USD","LU1066051811.HKD","LU1291159041.SGD","XLV","LU0861579265.USD","LU0965509283.SGD","TRUH","LU2023250843.SGD","LU0162691827.USD","LU0208291251.USD","LU0942090050.USD","LU1035773651.USD","LU2491050071.SGD","LU0289739699.SGD","LU0868494708.USD","LU2461242641.AUD","IE00BBT3K403.USD","LU0265550359.USD","SG9999014559.SGD","MRK","LU0130517989.USD","RXL","SGXZ57979304.SGD","LU0098860793.USD","LU1116320901.HKD","LU1934455863.HKD","VHT","IE00B1BXHZ80.USD","LU0069063385.USD","LU2125154778.USD","LU1917777945.USD","LU1069347547.HKD","LU2106854487.HKD","LU1929549753.HKD","LU0058720904.USD","LU1585245621.USD","LU0980610538.SGD","LU2491050154.USD","BK4533","SG9999014575.USD","LU0477156953.USD","LU2125909593.SGD","LU0965508806.USD","BK4534","LU0266013472.USD","LU0057025933.USD","BK4550","LU0432979614.USD","SG9999002232.USD","SG9999014542.SGD","LU1201861249.SGD","IE0002141913.USD","IE00BSNM7G36.USD","JDOC","LU2361044949.HKD","LU2357627491.SGD","LU0965509010.AUD","LU2361045086.USD","LU1066051498.USD","LU0648001328.SGD","LU0511384066.AUD","LU0124676726.USD","LU1093756168.USD","LU1934455194.USD","IE00BJJMRZ35.SGD","LU1989772840.SGD","IE000M9KFDE8.USD","PAWZ","LU1430594728.SGD","SG9999013999.USD","LU1941712348.USD","FTXH","SG9999001440.SGD","LU0006306889.USD","LU1057294990.SGD","LU0689626769.HKD","HRTS","LU0868494617.USD","LU1032466523.USD","LU1934455277.USD","LU2324357040.USD","BK4585","LU0238689110.USD","LU0265550946.USD","LU1941712264.USD","LU1037948897.HKD","LU0234572021.USD","SG9999014567.USD","LU0320765489.SGD","LU0203345920.USD","SG9999001176.SGD","LU2491049909.HKD","LU0211331839.USD","SG9999015358.SGD","LU1066051225.USD","LU1571399168.USD","LU1974910355.USD","IE00BLSP4452.SGD","LU1989771016.USD","LU0072461881.USD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669614575","title":"U.S. FDA Approves Update to the Label for Winrevair to Include Data from the Phase 3 Hyperion Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2669614575","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669614575?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:48","pubTimestamp":1790074133,"startTime":"0","endTime":"0","summary":"BRIEF-U.S. FDA Approves Update To The Label For Winrevair To Include Data From The Phase 3 Hyperion Trial Evaluating Adults Recently Diagnosed With Pulmonary Arterial HypertensionSept 22 (Reuters)-Mer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABMLGGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU1923622614.USD","LU2125154935.USD","RXL","LU0211331839.USD","LU1934455863.HKD","LU1699723380.USD","LU0124676726.USD","LU1116320901.HKD","LU1066051811.HKD","LU2461242641.AUD","IYH","LU1116320737.USD","GDOC","IE00BJJMRZ35.SGD","LU0072461881.USD","LU1934455277.USD","IE00BLSP4239.USD","LU1585245621.USD","BK4533","LU0266013472.USD","LU2023250843.SGD","SG9999001440.SGD","SG9999015358.SGD","LU0070302665.USD","LU0965508806.USD","BK4007","IE00BN8TJ469.HKD","BK4516","JDOC","LU0098860793.USD","LU0320765646.SGD","LU0980610538.SGD","LU2125154778.USD","LU1430594728.SGD","LU0868494617.USD","LU1201861249.SGD","SG9999013999.USD","LU1989771016.USD","LU0648001328.SGD","LU0511384066.AUD","SG9999014567.USD","LU1571399168.USD","BK4559","MRK","BMED","LU2361045086.USD","LU2357627491.SGD","IE00B4R5TH58.HKD","HRTS","LU0965509101.SGD","SG9999015341.SGD","BK4588","LU0861579265.USD","LU1066051225.USD","PPH","LU2112291526.USD","LU0203345920.USD","LU0320765489.SGD","LU1093756168.USD","LU1162221912.USD","LU1032466523.USD","LU0289961442.SGD","TRUH","LU2491049909.HKD","LU0965509010.AUD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU0058720904.USD","BK4550","LU0234572021.USD","FHLC","LU0122379950.USD","LU0432979614.USD","LU2324357040.USD","SG9999014575.USD","LU2491050154.USD","IE00BBT3K403.USD","LU2089984988.USD","LU0965509283.SGD","LU1974910355.USD","LU0130517989.USD","IE00B1BXHZ80.USD","LU2468319806.SGD","LU0106261372.USD","LU1093756325.SGD","LU2361044949.HKD","LU1066051498.USD","LU0208291251.USD","LU2023250504.SGD","LU1929549753.HKD","SG9999014542.SGD","SG9999002232.USD","LU2360032135.SGD","LU0289739343.SGD","FTXH","IE00BLSP4452.SGD","LU1037948541.HKD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0057025933.USD","LU0289739699.SGD","LU1061106388.HKD","PAWZ","LU1066053197.SGD","LU0069063385.USD","LU0689626769.HKD","LU2125909247.SGD","LU1941712348.USD","LU1989772840.SGD","LU2491050071.SGD","SG9999001176.SGD","LU0162691827.USD","LU1934455194.USD","LU0238689110.USD","LU1035773651.USD","LU0265550359.USD","IE0009355771.USD","LU1989772923.USD","LU2106854487.HKD","LU0265550946.USD","LU0942090050.USD","LU1037948897.HKD","XLV","VHT","LU0203347892.USD","BK4585","LU2361044865.SGD","LU0006306889.USD","IHE","LU0859254822.USD","LU1023059063.AUD","SG9999014559.SGD","IE00BJT1NW94.SGD","LU0130102774.USD","SG9999001176.USD","SG9999002224.SGD","IE00BSNM7G36.USD","LU0477156953.USD","BK4534","LU2433249047.HKD","LU0868494708.USD","LU1941712264.USD","LU1917777945.USD","LU1069347547.HKD","LU1983299246.USD","LU0985320562.USD","LU0472753341.HKD","LU2125909593.SGD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669452731","title":"Merck Says Phase 3 Hyperion Trial Shows Winrevair Cuts PAH Clinical Worsening Risk 76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669452731","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669452731?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:45","pubTimestamp":1790073940,"startTime":"0","endTime":"0","summary":"Merck says Phase 3 HYPERION trial shows WINREVAIR cuts PAH clinical worsening risk 76%Merck won a US label update for PAH drug Winrevair to add Phase 3 HYPERION efficacy and safety results.HYPERION re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL4y9kWJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","LU2468319806.SGD","LU1929549753.HKD","BK4559","IXJ","LU1585245621.USD","LU1069347547.HKD","LU0320765646.SGD","LU1057294990.SGD","LU0289961442.SGD","SG9999014542.SGD","SG9999013999.USD","LU1699723380.USD","BK4550","LU0070302665.USD","LU2112291526.USD","LU0980610538.SGD","LU1037948897.HKD","LU0106261372.USD","LU2125909593.SGD","LU1917777945.USD","LU2106854487.HKD","LU1093756168.USD","LU1934455863.HKD","LU0266013472.USD","LU0058720904.USD","BMED","IE0009355771.USD","LU1066051498.USD","LU2433249047.HKD","HRTS","LU2125154778.USD","LU1934455277.USD","IE00BBT3K403.USD","LU0098860793.USD","IE000M9KFDE8.USD","LU1923622614.USD","LU0289739699.SGD","LU1934455194.USD","SG9999001176.USD","XLV","SG9999001176.SGD","PPH","LU1035773651.USD","LU0289739343.SGD","LU0162691827.USD","LU0238689110.USD","LU2125154935.USD","SG9999002232.USD","LU1201861249.SGD","MRK","LU0942090050.USD","LU1116320901.HKD","BK4007","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD","LU0965509101.SGD","IHE","LU2023250504.SGD","SG9999015341.SGD","IE00BJJMRZ35.SGD","LU0648001328.SGD","LU0859254822.USD","LU2357627491.SGD","RXL","LU0965509010.AUD","LU0069063385.USD","LU1974910355.USD","SG9999002224.SGD","LU0057025933.USD","BK4533","GDOC","LU1430594728.SGD","LU0985320562.USD","LU0861579265.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0124676726.USD","LU0265550359.USD","LU1291159041.SGD","LU1023059063.AUD","LU1941712264.USD","SG9999014559.SGD","LU1032466523.USD","LU1989771016.USD","LU2361044949.HKD","LU0965509283.SGD","LU2361045086.USD","LU2361044865.SGD","LU0689626769.HKD","LU1983299246.USD","LU0203347892.USD","LU0868494708.USD","LU0211331839.USD","IYH","LU0122379950.USD","LU2324357040.USD","LU1116320737.USD","LU1066051811.HKD","LU0234572021.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","LU0203345920.USD","LU1066053197.SGD","LU1162221912.USD","LU1061106388.HKD","BK4588","SG9999015358.SGD","SG9999001440.SGD","LU0823416689.USD","TRUH","LU2360032135.SGD","LU0432979614.USD","SG9999014575.USD","LU0208291251.USD","LU0265550946.USD","LU1571399168.USD","BK4585","JDOC","SG9999014567.USD","BK4534","LU1989772923.USD","LU1941712348.USD","FTXH","VHT","IE00B1BXHZ80.USD","LU0477156953.USD","LU0130517989.USD","LU1989772840.SGD","LU2125909247.SGD","LU2461242641.AUD","LU0006306889.USD","LU0130102774.USD","IE0002141913.USD","LU0320765489.SGD","LU0868494617.USD","LU0472753341.HKD","IE00B2B36J28.USD","LU1093756325.SGD","LU1037948541.HKD","LU0511384066.AUD","LU2089984988.USD","IE00BSNM7G36.USD","LU2491050071.SGD","PAWZ","LU2491049909.HKD","LU0072461881.USD","BK4516","LU2491050154.USD","LU2023250843.SGD","LU1066051225.USD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451651","title":"Novo Nordisk Investor Day Disappointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669451651?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:39","pubTimestamp":1790073540,"startTime":"0","endTime":"0","summary":"1038 GMT - Novo Nordisk's capital markets day announcements, including the diversification plan and a vague midterm sales target, disappointed investors, AlphaValue analyst Abhishek Raval writes. \"Against the backdrop of excessive dependency on a single molecule, aggressive and heavy diversification bets, along with impeccable commercial execution, are the need of the hour.\" However, the markets have their reservations, Raval says. The commercial success of oral Wegovy, some promising late-stage assets, and the firepower for acquisitions provide reasons to bet on Novo, which is available at a discount to peers, he adds. AlphaValue rates the Danish drugmaker's stock at buy with a 450 Danish kroner target price. Shares fall 0.2% to 259.40 kroner.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","LU1093756168.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","NVOX","NVOH","BK4599","OZEM","PPH","NVO","NVOC","BK4007","THNR","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669914330","title":"AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669914330","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669914330?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:55","pubTimestamp":1790070911,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced that the European Commission has approved Rinvoq for the treatment of active polyarticular juvenile idiopathic arthritis in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-ec-approves-rinvoq-to-treat-polyarticular-juvenile-idiopathic-arthritis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-ec-approves-rinvoq-to-treat-polyarticular-juvenile-idiopathic-arthritis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B42XCP33.USD","LU1934455277.USD","MEDX","ABBV","LU1074936037.SGD","IE00BJT1NW94.SGD","LU1670628061.USD","FTXH","AGNG","PPH","IXJ","JDOC","SG9999015945.SGD","GLAM","LU0234570918.USD","LU0738911758.USD","TRUH","LU0203347892.USD","IE00BVYPNW00.USD","LU2089284900.SGD","IE0004445239.USD","VHT","LU0943347566.SGD","IYH","LU2357627491.SGD","LU2089984988.USD","LU1923622614.USD","LU0708994859.HKD","LU0289739343.SGD","FHLC","LU0432979614.USD","LU0456855351.SGD","LU1093756168.USD","PJP","LU1718418525.SGD","LU2129689514.USD","RXL","LU0198837287.USD","XLV","LU1732799900.SGD","LU0861579265.USD","SG9999015986.USD","LU0256863902.USD","LU1732800096.USD","IE0009355771.USD","EPV","IE00BLSP4239.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU0395794307.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669713148","title":"Market Chatter: Novo Nordisk CEO Eyes M&A to Fill Gaps in Drug Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2669713148","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669713148?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:52","pubTimestamp":1790070723,"startTime":"0","endTime":"0","summary":"Novo Nordisk  Chief Executive Mike Doustdar said the pharmaceutical major is considering acquisitions to bolster its position in the weight-loss drug market, CNBC reported Tuesday, citing an interview.Doustdar said Novo Nordisk will look for weaknesses in its drug lineup and consider acquisitions of treatments that could help close those gaps, CNBC reported.Doustdar said that the market reaction to its new long-term strategy and growth targets showed that the company still has work to do in convincing some investors.Novo Nordisk did not immediately reply to MT Newswires' request for comment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BKVL7J92.USD","BK4588","LU1093756325.SGD","NVOC","IE00BZ1G4Q59.USD","NVOX","BK4585","PPH","THNR","BK4532","NVOH","BK4007","OZEM","NVO","LU1093756168.USD","BK4599","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143804","title":"Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143804","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143804?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:43","pubTimestamp":1790070183,"startTime":"0","endTime":"0","summary":"Novo shares fell 7.96% to $39.80 on Monday after its growth strategy, disclosed at its Capital Markets Day in London, failed to impress investors\n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-stock-nvo-deutsche-bank-keeps-sell-rating-says-growth-strategy-underwhelming-on-multiple-fronts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-stock-nvo-deutsche-bank-keeps-sell-rating-says-growth-strategy-underwhelming-on-multiple-fronts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1093756325.SGD","BK4585","BK4599","THNR","NVOX","IE00BZ1G4Q59.USD","NVOC","OZEM","NVO","PPH","BK4588","BK4007","LU1093756168.USD","LU0154236417.USD","NVOH","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486461","title":"Novo Nordisk (0QIU) Receives a Hold from Berenberg Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:15","pubTimestamp":1790068532,"startTime":"0","endTime":"0","summary":"In a report released today, Kerry Holford from Berenberg Bank maintained a Hold rating on Novo Nordisk, with a price target of DKK305.00. Holford c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","BK4588","LU1093756325.SGD","BK4599","OZEM","THNR","NVO","NVOH","BK4007","NVOX","IE00BZ1G4Q59.USD","LU0154236417.USD","NVOC","PPH","BK4585","BK4532","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110697","title":"Novo Nordisk Investors Remain Nervous, but Share Drop an Overreaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110697","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669110697?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:11","pubTimestamp":1790068260,"startTime":"0","endTime":"0","summary":"0909 GMT - Novo Nordisk's 8% share price fall following the investor day is an overreaction, but proves that investors remain nervous about 2027, with expected price pressure and CagriSema drug launch skepticism, Berenberg analysts write. The Novo story appears more interesting from 2028, with zenagamtide phase 3 data, CagriSema bone and muscle function data and multiple phase 1 and 2 readouts, the bank says. The event provided a comprehensive overview of the company's strategy, R&D pipeline and business operations, but offered only incremental strategic insights, it adds. The 2030 and 2035 sales ambitions were also outlined, which are broadly in line with expectations. Understanding the need to quickly diversify the portfolio ahead of U.S./EU semaglutide patent expiry early next decade, Novo aims to significantly speed up development and supplement the internal pipeline. Shares fall 0.7%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1093756325.SGD","BK4585","BK4599","THNR","NVOX","IE00BZ1G4Q59.USD","NVOC","OZEM","NVO","PPH","BK4588","BK4007","LU1093756168.USD","LU0154236417.USD","NVOH","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141741","title":"Novo Nordisk's Underwhelming Investor Day Met with Punishing Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141741","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141741?lang=en_us&edition=fundamental","pubTime":"2026-09-22 15:41","pubTimestamp":1790062860,"startTime":"0","endTime":"0","summary":"0740 GMT - Novo Nordisk's investor day underwhelmed on multiple fronts, relative to some of the more optimistic expectations heading into the event, Deutsche Bank analyst Emmanuel Papadakis writes. \"Whilst the event provided both a helpful and thorough review of the business outlook as well as a strategic refresh, it was met with a fairly punishing market response.\" The bank says there was largely a reiteration of familiar strategic messaging and the mid-term building blocks, in addition to somewhat underwhelming mid-term guidance. There was also nothing of substance in terms of clinical data or assets, and little clarity on M&A even though it clearly remains on the agenda, Deutsche Bank adds. The bank lowers its stock target price to 245 Danish kroner from 265 kroner and retains its sell rating. Shares fall 0.6% to 258.50 kroner.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4588","LU1093756325.SGD","NVOC","IE00BZ1G4Q59.USD","NVOX","BK4585","PPH","THNR","BK4532","NVOH","BK4007","OZEM","NVO","LU1093756168.USD","BK4599","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669119912","title":"AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669119912","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669119912?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:41","pubTimestamp":1790059265,"startTime":"0","endTime":"0","summary":"BRIEF-AbbVie Announces European Commission Approval Of RINVOQ (Upadacitinib)Sept 22 (Reuters)-AbbVie Inc.ABBV.N:ABBVIE ANNOUNCES EUROPEAN COMMISSION APPROVAL OF RINVOQ (UPADACITINIB) FOR THE TREATMENT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9MJJCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1236620834.HKD","LU1720051108.HKD","ABBV","GLAM","IE00B2B36J28.USD","LU1989772840.SGD","IXJ","LU1093756168.USD","TRUH","LU0114720955.EUR","LU1548497426.USD","LU2357627491.SGD","LU0211328371.USD","IE00BLSP4452.SGD","VHT","IE0002270589.USD","LU1732799900.SGD","LU0943347566.SGD","LU1989771016.USD","BK4550","LU0057025933.USD","LU0795875086.SGD","LU2112291526.USD","MEDX","RXL","SG9999015986.USD","XLV","BK4588","LU2023251221.USD","FHLC","LU0069063385.USD","LU0203347892.USD","LU0689626769.HKD","IYH","LU0029864427.USD","IE00BGHQF631.EUR","LU2129689514.USD","PJP","FTXH","LU1934455194.USD","IE00BN8TJ469.HKD","AGNG","IE000MB6IJN5.SGD","IE00BBT3K403.USD","IE00B42XCP33.USD","LU0256863902.USD","LU0985320562.USD","PPH","JDOC","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116407","title":"Novo Nordisk's Share Fall After Investor Day Seems Harsh","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116407","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116407?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:16","pubTimestamp":1790057760,"startTime":"0","endTime":"0","summary":"0616 GMT - Novo Nordisk's 8% share decline following the Wegovy maker's investor day on Monday suggests investors weren't convinced about its growth plans, but this seems like a somewhat harsh reaction, Jyske Bank's Henrik Hallengreen Laustsen writes. \"The strategy and its key components appear sound, if not impressive.\" However, following several disappointments from Novo, the market wants to see concrete clinical and commercial evidence, Jyske Bank adds. Novo presented ambitions for industry-level growth through 2030 and stable margins, which seemed slightly underwhelming relative to market expectations, the bank says. It maintains its hold rating on the stock with a 330 Danish kroner target price.Jyske Bank cites uncertainty on growth prospects, pressure from semaglutide's 2032 patent expiry, fair valuation, and limited near-term news flow. Shares closed Monday at 260 kroner.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","BK4588","OZEM","NVO","IE00BKVL7J92.USD","NVOX","THNR","BK4599","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU1093756168.USD","NVOC","LU0154236417.USD","NVOH","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116311","title":"AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116311","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116311?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:01","pubTimestamp":1790056875,"startTime":"0","endTime":"0","summary":"AbbVie says EU approves Rinvoq for children with polyarticular juvenile idiopathic arthritisEuropean Commission cleared AbbVie’s Rinvoq for active polyarticular juvenile idiopathic arthritis in patien","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1SztCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051108.HKD","IE00BSNM7G36.USD","LU0320765646.SGD","JDOC","LU0965508806.USD","LU1732799900.SGD","LU2125909593.SGD","LU2347655156.SGD","LU2112291526.USD","ABBV","BK4588","IXJ","LU0820561909.HKD","LU1989771016.USD","SG9999015986.USD","LU0823416689.USD","LU0965509283.SGD","LU2357627491.SGD","VHT","XLV","FHLC","IE00BJT1NW94.SGD","LU1236620750.USD","LU0912757837.SGD","LU1983299246.USD","LU0057025933.USD","MEDX","PJP","LU0868494617.USD","FTXH","LU0472753341.HKD","IE000SO60NU8.SGD","BK4550","IE00BVYPNV92.GBP","LU0882574055.USD","BK4533","TRUH","IE00BVYPNW00.USD","LU0058720904.USD","LU0256863811.USD","LU0985320562.USD","LU0432979614.USD","RXL","AGNG","LU1989772840.SGD","PPH","GLAM","IYH","LU1934455277.USD","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669844116","title":"Abbvie Announces European Commission Approval of Rinvoq® (Upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669844116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669844116?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:00","pubTimestamp":1790056801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9MJJCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE000BZT7R73.USD","FTXH","IYH","LU0661504455.SGD","LU1551013425.SGD","LU1720051108.HKD","XLV","IE00BGHQF631.EUR","LU0057025933.USD","IE00BFTCPJ56.SGD","LU0943347566.SGD","GLAM","LU0114720955.EUR","LU1934455863.HKD","SG9999011175.SGD","LU1162221912.USD","FHLC","IE0002141913.USD","LU2089283258.USD","LU0124676726.USD","IXJ","LU1989771016.USD","LU0689472784.USD","LU0128525929.USD","LU1923622614.USD","MEDX","PJP","VHT","LU0211327993.USD","LU2468319806.SGD","PPH","LU0965509101.SGD","LU0859254822.USD","TRUH","LU1934455194.USD","LU1267930573.SGD","LU2237443549.SGD","IE000MB6IJN5.SGD","LU1718418525.SGD","LU0456855351.SGD","LU1496350171.SGD","LU0708994859.HKD","JDOC","RXL","AGNG","LU0069063385.USD","LU0965508806.USD","LU1023059063.AUD","BK4581","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116885","title":"Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116885?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:00","pubTimestamp":1790056801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9MJJCN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","AGNG","LU0170899867.USD","RXL","LU0124676726.USD","LU1934455277.USD","PPH","JDOC","FHLC","LU0256863902.USD","FTXH","LU1551013425.SGD","LU1934455194.USD","LU2125909593.SGD","LU1670628061.USD","PJP","LU1732800096.USD","LU0965508806.USD","BK4581","IYH","IE00B3PB1722.GBP","LU0511384066.AUD","LU0395794307.EUR","IE00BN8TJ469.HKD","LU0432979614.USD","LU2089984988.USD","LU0114720955.EUR","GLAM","LU1074936037.SGD","XLV","LU0965509101.SGD","LU1839511570.USD","LU0234572021.USD","VHT","BK4534","LU1670627923.USD","LU2357627491.SGD","LU0320765646.SGD","LU1023059063.AUD","BK4533","LU0158827948.USD","LU1244550577.SGD","TRUH","LU0545039389.USD","SG9999001440.SGD","LU1057294990.SGD","LU1267930573.SGD","ABBV","IXJ","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669115129","title":"Novo Nordisk Investor Day Offered Little to Excite","url":"https://stock-news.laohu8.com/highlight/detail?id=2669115129","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669115129?lang=en_us&edition=fundamental","pubTime":"2026-09-22 13:40","pubTimestamp":1790055600,"startTime":"0","endTime":"0","summary":"0540 GMT - Novo Nordisk's capital markets day offered little to change Citi's cautious view, with topline growth ambitions in line with consensus but margins below expectations. The company is positioning for the post-semaglutide era through more than five planned multi-blockbuster launches by 2030 and more than 150 billion Danish kroner of pipeline sales by 2035, which is largely reflected in consensus, Citi says. Updated oral obesity capacity and more than 20 Wegovy pill market launches in 2027 are encouraging, but execution is key. Novo also intends to broaden growth beyond obesity and diabetes into cardiovascular, liver, blood, and endocrine disorders, while a 2027 launch of CagriSema is a key opportunity to beat consensus, Citi adds. \"M&A focus remains bolt-on but management did not rule out a large transaction, creating some inherent risk.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","BK4585","NVOX","BK4007","BK4532","OZEM","NVO","LU1093756325.SGD","LU1093756168.USD","BK4599","BK4588","IE00BZ1G4Q59.USD","NVOH","LU0154236417.USD","PPH","NVOC","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669111591","title":"Novo Nordisk Highlights Building Blocks, but More Data Needed to Reassure Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669111591","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669111591?lang=en_us&edition=fundamental","pubTime":"2026-09-22 13:30","pubTimestamp":1790055000,"startTime":"0","endTime":"0","summary":"0527 GMT - Novo Nordisk used its investor day to highlight potential building blocks that underpin mid-term growth expectations, but more data is needed to increase investor confidence, J.P. Morgan analysts write. The company provided mid-term targets for topline growth from 2026-30 in the mid-single-digit range and an expectation for adjusted operating profit margins to remain broadly stable. These targets largely underpin consensus expectations for sales, but depend on the Wegovy oral pill and CagriSema rollouts, and delivery of a competitive zenagamtide obesity and weight-loss drug profile in phase-3 trials in 2028, the bank adds. The company highlighted three further oral obesity products beyond Wegovy that it expects will further drive its market share in this segment. Shares fell 7.7% Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","LU0154236417.USD","NVOX","BK4585","PPH","OZEM","BK4007","LU1093756325.SGD","THNR","NVOH","BK4532","BK4599","IE00BKVL7J92.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669619560","title":"Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2669619560","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669619560?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:55","pubTimestamp":1790027717,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company  said Monday it has broken ground on a $6.5 billion manufacturing facility in Houston, Texas, that will produce its oral GLP-1 drug Foundayo along with other small-molecule medicines and advanced therapeutics.Lilly said the facility is expected to create more than 600 high-wage jobs and roughly 4,000 construction jobs.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443622.USD","SG9999001176.USD","LU2089984988.USD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","LU0672654240.SGD","LU2491049909.HKD","LU2602419157.SGD","IHE","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1035775433.USD","LU0320765059.SGD","LU0823434740.USD","BK4534","LU2237438978.USD","LU2111349929.HKD","LU1291159041.SGD","LU0058720904.USD","IXJ","WDNA","LU2023250504.SGD","LU2168564065.EUR","LU1868836914.USD","PPH","XLV","BK4581","CANC","LU2023250330.USD","MEDI","SG9999015986.USD","IE00BFSS8Q28.SGD","GB00BDT5M118.USD","LU1069344957.HKD","LU0456855351.SGD","LU1988902786.USD","LU0266013472.USD","LU0820561909.HKD","SG9999015978.USD","BK4599","LU1804176565.USD","ILDR","IE0004445015.USD","LU1983299246.USD","ELIS","LU0689472784.USD","LU2471134879.HKD","LU2063271972.USD","LU0323591593.USD","LU2462591350.SGD","LU0345770308.USD","LU2491050071.SGD","LU2750360641.GBP","SGXZ31699556.SGD","TMED","FTXH","LU1232071149.USD","IE00BJLML261.HKD","LU0256863811.USD","LU0683600562.USD","SG9999014898.SGD","SGXZ57979304.SGD","LU0114720955.EUR","LU1127390331.HKD","LU0354030438.USD","LU0133085943.USD","LU2361045086.USD","LU2756315664.SGD","SG9999015952.SGD","LU0882574055.USD","LU0354030511.USD","LU0320765992.SGD","LU0096364046.USD","LU1691799644.USD","LU2237443382.USD","LU2462157665.USD","LU2106854487.HKD","LU0417517546.SGD","BK4588","LU0708995401.HKD","LU0823434583.USD","IE0002141913.USD","LU0943347566.SGD","LU1551013425.SGD","LU2108987350.USD","CURE","GDOC","LU2361044865.SGD","LU1061106388.HKD","LU1868837300.USD","LU2237443549.SGD","BK4516","IE00B4JS1V06.HKD","LU1720051017.SGD","LU0174119429.USD","PJP","LU2112291526.USD","IE0009355771.USD","BK4585","LU0640476718.USD","LU0820562030.AUD","LU2237443895.HKD","IE00BKPKM429.USD","IE00BN29S564.USD","LU2471134523.USD","LU2168563687.JPY","LU2023251221.USD","LU2491050154.USD","LU0109391861.USD","LU2271345857.HKD","LU2264538146.SGD","SG9999018857.SGD","LLYZ","IE00B1BXHZ80.USD","LU0094547139.USD","LU0964807845.USD","SG9999001176.SGD","IE0005OL40V9.USD","LU1093756325.SGD","BK4007","LU2168564495.EUR","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU1093756168.USD","LU2417539215.USD","LU1917777945.USD","LU2168564222.USD","LU0079474960.USD","LU0256863902.USD","LU2089284900.SGD","IE00B775H168.HKD","LU0225283273.USD","LU0122379950.USD","SG9999013999.USD","LU1974910355.USD","IE00BJJMRX11.SGD","IE00BK4W5L77.USD","AGNG","LU1551013342.USD","LU2471134796.USD","LU2357305700.SGD","LU2896262040.SGD","HRTS","LU2324357040.USD","LU2461242641.AUD","LU2265009873.SGD","IE0004445239.USD","LU1023059063.AUD","SG9999014906.USD","LU2746668461.USD","LU1145028129.USD","LU2237443465.HKD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","LU1548497426.USD","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU0109394709.USD","LU1623119135.USD","LU0316494557.USD","LU0203202063.USD","LU2236285917.USD","RXL","LU0345770993.USD","FHLC","LLYX","LU0353189763.USD","LU2168564149.EUR","LU0234572021.USD","LU2361044949.HKD","LU2237443978.SGD","SG9999018865.SGD","SGXZ81514606.USD","SG9999017495.SGD","LU0385154629.USD","LU2087625088.SGD","LU1280957306.USD","LU2746668974.SGD","LU2756315318.SGD","VHT","LU1366192091.USD","THNR","LU0097036916.USD","IE00BKDWB100.SGD","LU0061475181.USD","LU0882574139.USD","LU1868836757.USD","LU2211815571.USD","LU2750360997.AUD","SG9999014914.USD","LU1868836591.USD","IE00B2B36J28.USD","LU1712237335.SGD","LU0466842654.USD","MEDX","LU0786609619.USD","LU1267930730.SGD","LU0198837287.USD","IE00BFSS7M15.SGD","LU0289739699.SGD","LU2471134952.CNY","LU0353189680.USD","LU2552382058.USD","ELIL","SG9999014880.SGD","IE00BK4W5M84.HKD","LU0238689110.USD","LU0158827948.USD","LU0203201768.USD","LU0106261372.USD","LU1057294990.SGD","TRUH","LU0820561818.USD","LU1868837136.USD","LU0823416689.USD","LU2360106947.USD","LU2552382132.HKD","SGXZ99366536.SGD","LU2089283258.USD","LU1629891620.HKD","SG9999015945.SGD","IYH","LU0006306889.USD","IE0001KFT4U8.USD","LU0889565916.HKD","LU1323610961.USD","LU1064131342.USD","BK4533","LU0158827781.USD","LU0210536198.USD","LU1720051108.HKD","LU1979441026.SGD","LU1989771016.USD","LU2456880835.USD","LU0471298777.SGD","LLII","LU0471298694.HKD","LLY","LU1814569148.SGD","LU2552382215.SGD","LU0787776722.HKD","MHIP","OZEM","LU2213496289.HKD","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669955941","title":"Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston","url":"https://stock-news.laohu8.com/highlight/detail?id=2669955941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669955941?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:44","pubTimestamp":1790027083,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0IB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00B2B36J28.USD","LU0823434583.USD","LU0316494557.USD","LU0256863902.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0225283273.USD","LU2089283258.USD","LU2211815571.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU0109391861.USD","LU2023251221.USD","SG9999014898.SGD","LU2471134952.CNY","CURE","LU2750360641.GBP","LU0353189680.USD","LU0823434740.USD","LU0122379950.USD","ELIS","LU0820561818.USD","SG9999018865.SGD","LU0094547139.USD","SG9999013999.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BFSS7M15.SGD","VHT","LU0079474960.USD","IYH","LU2746668461.USD","LU2756315318.SGD","LU1868836591.USD","LU2087625088.SGD","LU2168564065.EUR","BK4585","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","LU1979441026.SGD","LU2462157665.USD","IE0001KFT4U8.USD","LU1917777945.USD","LU1035775433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU1366192091.USD","IE00B4R5TH58.HKD","ILDR","LU0256863811.USD","BK4581","SG9999018857.SGD","SGXZ31699556.SGD","LLYX","LU1548497426.USD","LU2552382132.HKD","WDNA","LU1323610961.USD","LU2896262040.SGD","FHLC","LU1145028129.USD","LU0203202063.USD","IE00BJLML261.HKD","LU0097036916.USD","SG9999001176.USD","LU0471298777.SGD","LU1720051017.SGD","LU2602419157.SGD","LU2552382058.USD","IE00BKDWB100.SGD","LU1974910355.USD","LU1291159041.SGD","LU2023250330.USD","LU0266013472.USD","LU2023250504.SGD","LLII","LU2111349929.HKD","LU2746668974.SGD","LU0823416689.USD","IXJ","LU0889565916.HKD","LU0964807845.USD","PPH","LU0417517546.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LLYZ","MEDX","LU0345770308.USD","LU0689472784.USD","LU2456880835.USD","PJP","LU2491050154.USD","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU1551013342.USD","RXL","LU0289739699.SGD","LU0787776722.HKD","THNR","IE00BKPKM429.USD","IE0004445239.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0106261372.USD","LU0323591593.USD","LU1232071149.USD","LU2237443978.SGD","HRTS","LU0320765992.SGD","IE00BK4W5L77.USD","LU2756315664.SGD","SG9999001176.SGD","LU2028103732.USD","LU1061106388.HKD","LU1551013425.SGD","ELIL","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0943347566.SGD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","MHIP","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0471298694.HKD","LU2361045086.USD","LU0096364046.USD","LU1720051108.HKD","LU0385154629.USD","LU0882574139.USD","IE0005OL40V9.USD","LU2361044949.HKD","LU2237438978.USD","SG9999014906.USD","JDOC","BK4599","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU2324357040.USD","LU2112291526.USD","BK4588","BK4007","LU2750360997.AUD","LU1127390331.HKD","LU2106854487.HKD","LU2236285917.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","IE0004445015.USD","LU1629891620.HKD","CANC","LU0158827948.USD","LU0238689110.USD","LU0345770993.USD","LU1868836757.USD","LU1691799644.USD","SGXZ81514606.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0672654240.SGD","BK4516","LU0882574055.USD","TRUH","LU0466842654.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LU2089984988.USD","LU2237443622.USD","LU0820562030.AUD","LU1712237335.SGD","LU1093756168.USD","LU0114720955.EUR","LU0058720904.USD","LU2213496289.HKD","LU1988902786.USD","LU2491049909.HKD","AGNG","SG9999015986.USD","TMED","LU2168564222.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0234572021.USD","LU0061475181.USD","LU0174119429.USD","LU0354030438.USD","LU2237443465.HKD","LU1057294990.SGD","LU2237443549.SGD","SG9999015978.USD","LU1989771016.USD","LU2471134523.USD","LU0820561909.HKD","LU1267930730.SGD","LU0133085943.USD","SG9999014880.SGD","IE0002141913.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2168564149.EUR","LU2417539215.USD","LU0198837287.USD","LU2471134796.USD","SG9999015945.SGD","LU0210536198.USD","LU2491050071.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LLY","GDOC","IE00BWXC8680.SGD","LU2462591350.SGD","SGXZ57979304.SGD","XLV","LU2089284900.SGD","LU2360106947.USD","SG9999014914.USD","GB00BDT5M118.USD","LU2237443895.HKD","MEDI","LU2357305700.SGD","LU2471134879.HKD","SG9999017495.SGD","LU2265009873.SGD","LU0683600562.USD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","OZEM","SG9999015952.SGD","LU1868837300.USD","LU1023059063.AUD","IHE","LU2552382215.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669597195","title":"Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo","url":"https://stock-news.laohu8.com/highlight/detail?id=2669597195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669597195?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:44","pubTimestamp":1790027083,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0IB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU0787776722.HKD","SG9999018865.SGD","ILDR","BK4516","BK4599","ELIS","LU1983299246.USD","LU2237443622.USD","SGXZ81514606.USD","LU2462157665.USD","LU2168564149.EUR","LU2089284900.SGD","LU2168564065.EUR","LU1623119135.USD","LU2023250330.USD","SG9999015952.SGD","IE00B1XK9C88.USD","LU1720051017.SGD","LU0256863902.USD","LU2750360641.GBP","SGXZ31699556.SGD","PJP","MEDX","LU0823416689.USD","LU0109391861.USD","SG9999017495.SGD","LU1712237335.SGD","LU0006306889.USD","GB00BDT5M118.USD","LU0174119429.USD","LU1291159041.SGD","SG9999013999.USD","LU0786609619.USD","LU2471134879.HKD","LU1232071149.USD","LU1868837300.USD","SG9999014906.USD","THNR","LU0354030511.USD","AGNG","IE00B775H168.HKD","LU2471134523.USD","LU2471134796.USD","LU2063271972.USD","LU0708995401.HKD","IE00BFSS8Q28.SGD","LU2106854487.HKD","LU2491049909.HKD","SG9999014880.SGD","LU2324357040.USD","LU2746668461.USD","LU1551013425.SGD","LU0198837287.USD","LU0061475181.USD","IE00B4JS1V06.HKD","LU1366192091.USD","IE00BK4W5M84.HKD","IE0004445015.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU1974910355.USD","LU0097036916.USD","LU2361045086.USD","LU2111349929.HKD","LU2211815571.USD","SG9999015978.USD","IE00BFSS7M15.SGD","LU0203202063.USD","LU2089283258.USD","LU0683600562.USD","LU0820561909.HKD","LU0320765059.SGD","LU1323610961.USD","LU1093756325.SGD","SGXZ57979304.SGD","OZEM","LU2552382215.SGD","LU0820562030.AUD","HRTS","LLYX","LU1548497426.USD","LU0158827781.USD","LU0210536198.USD","LU0079474960.USD","LLII","LU0385154629.USD","IE00BJJMRY28.SGD","CURE","LU1551013342.USD","CANC","LU0466842654.USD","LU1061106388.HKD","LU2357305700.SGD","IHE","LU0417517546.SGD","LU2746668974.SGD","LU0234572021.USD","LU0456855351.SGD","SG9999014898.SGD","LU2360106947.USD","LU0889565916.HKD","LU1280957306.USD","LLY","LU1804176565.USD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","BK4534","LU1145028129.USD","LU0823434583.USD","LU1023059063.AUD","LU1868836757.USD","LU0289739699.SGD","LU0345770308.USD","LU0820561818.USD","LU1720051108.HKD","LU1127390331.HKD","LU2417539215.USD","LU2552382132.HKD","LU2750360997.AUD","XLV","LU0225283273.USD","MEDI","TMED","IE00BFTCPJ56.SGD","LU0943347566.SGD","SG9999015945.SGD","LU2087625088.SGD","BK4588","IE00BK4W5L77.USD","LU0114720955.EUR","LU1035775433.USD","LU2756315664.SGD","LU1267930730.SGD","LU2552382058.USD","LU1814569148.SGD","LU2023250504.SGD","IE00BJJMRX11.SGD","LU2471134952.CNY","LU0471298777.SGD","LU1868836591.USD","LU2236285917.USD","VHT","LU0094547139.USD","LU1691799644.USD","IE00B4R5TH58.HKD","LU0203201768.USD","LU0238689110.USD","BK4533","LU1917777945.USD","LU0256863811.USD","MHIP","LU2361044949.HKD","LU2237438978.USD","LU2462591350.SGD","SGXZ99366536.SGD","IE00B7KXQ091.USD","LU2089984988.USD","LU2264538146.SGD","LU2491050154.USD","LU1069344957.HKD","JDOC","LU2602419157.SGD","LU2108987350.USD","SG9999001176.USD","LU2112291526.USD","LU1988902786.USD","BK4007","LU2237443382.USD","LU2271345857.HKD","IE00BKPKM429.USD","SG9999015986.USD","IYH","FTXH","LU1629891620.HKD","LU2028103732.USD","LU0058720904.USD","LU2213496289.HKD","LU0158827948.USD","LU0640476718.USD","LU1868836914.USD","LU2237443895.HKD","LU2265009873.SGD","LU1093756168.USD","LU2756315318.SGD","LU0323591593.USD","LU2168564222.USD","IE00BN29S564.USD","WDNA","FHLC","IE0002141913.USD","LU0882574139.USD","SG9999018857.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU2237443465.HKD","LU0354030438.USD","LU0672654240.SGD","LU2168564495.EUR","LLYZ","LU1989771016.USD","IXJ","LU0689472784.USD","IE00BWXC8680.SGD","LU0106261372.USD","IE0004445239.USD","LU0823434740.USD","SGXZ51526630.SGD","LU0964807845.USD","LU2468319806.SGD","LU2896262040.SGD","PPH","LU2491050071.SGD","LU0109394709.USD","LU0882574055.USD","TRUH","LU2456880835.USD","LU2237443549.SGD","LU0133085943.USD","BK4585","IE00B1BXHZ80.USD","LU1057294990.SGD","IE00BJLML261.HKD","IE0005OL40V9.USD","IE00BJT1NW94.SGD","LU0122379950.USD","LU2168563687.JPY","LU2237443978.SGD","LU2023251221.USD","LU2461242641.AUD","LU0266013472.USD","GDOC","LU1064131342.USD","LU1868837136.USD","RXL","LU1979441026.SGD","LU0096364046.USD","LU0353189763.USD","LU0353189680.USD","SG9999001176.SGD","LU0345770993.USD","LU0320765992.SGD","LU0316494557.USD","LU0471298694.HKD","LU2361044865.SGD","BK4581","ELIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":13,"totalSize":305,"code":"91000000","status":"200"}]}}